CRO (Contract Research Organization)

Operating an authorative global medical science network with Gemelli Hospital in Italy, Oxford Medical in England, Peking Union Medical College Hospital, Wuhan Union Hospital, Sichuan University Pharmacy Academy, and HERINGS Korea



Italy Roman Catholic University Gemelli Hospital

Prospective proof-of-concept and clinical study of gut microbiota in patients with metabolic syndrome, type 2 diabetes, and obesity.


In cooperation with Nuffield Medical Department of Medicine, Oxford, clinical research and develop a viral immune vaccine based on the patented technology of Recombinant Overlapping Peptides (ROP).

Peking Union Medical College Hospital

- A study on the mechanism of maternal onset of metabolic diseases and a model study on the prediction of the occurrence of GDM by establishing a specialized fund for metabolic disease
- Exploratory study on beneficial intestinal flora of healthy mothers and fetuses

Sichuan (四川) University

Joint research and development of nucleic acid vaccine delivery technology platform

Chinese Academy of Agricultural Sciences

Metabolic disease treatment candidate technology transfer


Research clinical design for digital therapeutics in combination with chemotherapy and prognosis management program for gastric cancer patients


Research for the use of AI systems in Digital Therapeutics, drug development, and other medical fields

Beijing Centre Ofmom

Conduct R&D and related clinical research such as observation of physiological indicators of mothers and newborns and analysis of breast milk components

Beijing Hanmi

Functional beneficial bacteria strain research and related clinical research